High-glucose level exerts deleterious effects on pancreatic β cells, but the mechanisms remain unclear. Calcium/calmodulin-dependent serine protein kinase (CASK) plays a vital role in neural development and release of neurotransmitters, and probably plays a role in the anchoring of insulin on pancreatic β cell membrane. Hypoxia-inducible factor 1α (HIF1α) is involved in β-cell dysfunction. The aim of this study was to provide some basic evidence that CASK could be involved in glucotoxicity-induced insulin secretion dysfunction mediated by HIF1α in INS-1E cells. CASK overexpression plasmid, HIF1α agonist (CoCl 2 ), and HIF1α selective inhibitor (KC7F2) were used. The results showed that chronic stimulation with high glucose could induce insulin secretion dysfunction in INS-1E β cells. Overexpression of CASK partially reversed the effects of high glucose on insulin secretion. CoCl 2 reduced the expression of CASK, but KC7F2 reversed the glucotoxicityinduced CASK level reduction. These results suggested that glucotoxicity-induced insulin secretion defects in INS-1E cells could be mediated by HIF1α via the down-regulation of CASK.
Introduction
Type 2 diabetes mellitus (T2DM) is a progressive disease characterized by high levels of blood glucose and defective insulin secretion. Prolonged exposure to chronic high-glucose levels exerts deleterious or toxic effects on β cells, which is termed as glucotoxicity [1] [2] [3] . The suggested cellular and biochemical mechanisms of glucotoxicity include β-cell overstimulation, oxidative stress, endoplasmic reticulum (ER) stress, protein glycation, advanced glycation endproducts (AGE) receptors, hexosamine pathway, protein kinase C (PKC) activation, inflammation, and hypoxia [4] . Understanding the mechanisms of glucotoxicity could provide novel treatment approaches for T2DM. Nevertheless, the mechanisms of β-cell glucotoxicity are not fully understood and require further research.
The calcium/calmodulin-dependent serine protein kinase (CASK) is a membrane-associated guanylate kinase and plays a crucial role in neuron development and neurotransmitter release [5, 6] . The similarities between islets cells and neurons are underscored by the demonstration of shared cell-autonomous developmental regulators and proteins known to be involved in granular secretion [7] [8] [9] [10] . In addition, it has been suggested that CASK is involved in exendin-4-induced insulin secretion by the cAMP-PKA pathway in INS-1 cells [11] . Recent studies by our group showed that forkhead box O1 (FOXO1) mediates the defects in palmitate-induced insulin granule exocytosis by down-regulation of CASK expression in INS-1 cells [12] . The results of electron microscopy images suggest that CASK seems to affect the insulin granules anchoring to the cell membrane [12] . These results suggest that CASK probably plays a vital role in pancreatic β cells, especially in the exocytosis process of insulin granules. Nevertheless, whether CASK is involved in glucotoxicityinduced defects of insulin secretion is not fully understood.
The Mat Inspector software (Genomatix GmbH, Munich, Germany) can be used to investigate the possible transcription factors that bind to the promoter of a specific gene [13] . With this software, the hypoxia-inducible factor 1α (HIF1α) was predicted to bind to the promoter of CASK [14] . Moreover, Manalo et al. [15] applied microarray analysis to analyze gene expression in human arterial endothelial cells exposed to a constitutively active form of HIF1α and suggested that CASK could be a downstream gene of HIF1α. It has been suggested that hypoxia may induce CASK alternative splicing in endothelial cells [16] . These results suggest that CASK may be regulated by HIF1α. Furthermore, it has also been shown that high-glucose levels may induce HIF1α [17] [18] [19] .
Based on these studies, we hypothesized that prolonged exposure to high-glucose levels may affect the expression of CASK and that this effect may be mediated by the up-regulation of HIF-1α, consequently affecting the insulin secretion of β cells. Therefore, the aim of this study was to provide some basic evidence that CASK could be involved in glucotoxicity-induced insulin secretion dysfunction mediated by HIF-1α in INS-1E cells.
Materials and Methods

Cell culture
The rat insulinoma INS-1E cell line was cultured in RPMI-1640 medium (GIBCO, Carlsbad, USA) supplemented with 6% FBS (Biological Industries, Kibbutz Beit-Haemek, Israel), 11.1 mM glucose (normal conditions), 10 mM HEPES, 2 mM L-glutamine, 50 μM β-mercaptoethanol, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37°C in an incubator with a humidified atmosphere containing 95% air and 5% CO 2 . The INS-1E cells were precultured in the medium shown above for 24 h. Then, INS-1E cells were treated with different concentrations (5.5, 11.1, 16.7, or 25 mM) of glucose for 48 h or treated with different concentrations (11.1 or 25 mM) of glucose for 24, 48, or 72 h. The cells were collected for mRNA analysis and western blot analysis.
Real-time PCR
The INS-1E cells were cultured in 3.5-cm plates for 48 h with different concentrations of glucose or drugs. Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, USA), according to the manufacturer's instructions. Total RNA (0.5 μg) was used for reverse transcription in a 10-μl final volume reaction with the AMV reverse transcriptase (Promega, Madison, USA). The real-time PCR with the corresponding cDNA, primers, and SYBR Green PCR master mix (Applied Biosystems, Foster City, USA) were performed using the LightCycler480 Sequence Detection System (Roche, Basel, Switzerland). The primers were as follows: CASK, forward 5′-AAGGAGAAAACTAAAGGGTGC-3′ and reverse 5′-GGAGGTA GGGTCTTCGGAG-3′; β-actin, forward 5′-GAACACGGCATTGTC ACCAACT-3′ and reverse 5′-GCCTGGATGGCTACGTACATG-3′; GAPDH, forward 5′-TGAACGGGAAGCTCACTGG-3′ and reverse 5′-TCCACCACCCTGTTGCTGTA-3′; HIF1α, forward 5′-TGGTG CTGATTTGTGAACCCATTCC-3′ and reverse 5′-CAGGGCATCGGG CTCTTTCTTAAG-3′; and HIF1β, forward 5′-ACCATTGTCCA GCCGTCATC-3′ and reverse 5′-CGAGTGCTAGAGGTCCAAG TT-3′. The PCR protocol consisted of 40 cycles of 30°C for 10 min, 42°C for 20 min, 99°C for 5 min, and 4°C for 5 min. All data were analyzed using β-actin as the reference. The data were analyzed using the 2 −ΔΔCt method.
Western blot analysis
INS-1E cells were lysed using ice-cold lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and complete proteinase inhibitor mixture (Roche Molecular Systems, Pleasanton, USA). Protein concentration was quantified using the DC protein assay kit (Bio-Rad, Hercules, USA). Equal amount of protein (30 μg) for each sample was separated by 10% SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, USA). Nonspecific protein interactions were blocked by incubating with 5% nonfat dry milk in TBST buffer [20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20 (pH 7.6)] at room temperature for 1 h. The membranes were incubated at 4°C overnight with rabbit anti-CASK antidody (1:800; Cell Signaling, Danvers, USA), mice anti-HIF1α antibody (1:800; Santa Cruz, Santa Cruz, USA), and rabbit anti-α-tubulin antibody (1:5000; Santa Cruz). After that, the blots were washed with TBST buffer and incubated with horseradish peroxide-conjugated anti-rabbit or antimouse secondary antibodies (1:3000; Santa Cruz) for 1 h at room temperature. The protein bands were visualized using enhanced chemiluminescence reagents (ECL Plus detection system; Amersham, Waukesha, USA). Prestained protein markers (New England Biolabs, Beverly, USA) were used as internal molecular weight standards.
Immunofluorescence assay Glucose-stimulated insulin secretion assay and potassium-stimulated insulin secretion assay . The supernatants were obtained to detect the insulin levels using radio-immunoassay (RIA), as previously described [12] .
Cell viability assay
Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, as previously described [20] . Briefly, the cells were seeded in 96-well plates and treated without (control) or with different concentrations of CoCl 2 or KC7F2 for 48 h. Then each well was supplemented with 10 μl MTT (Sigma) and incubated for 4 h at 37°C. The medium was then removed, and 150 μl DMSO (Sigma) were added to dissolve the MTT formazan. The optical density was read at 570 nm.
Cell transfection
The overexpression plasmid pEGFP-N2-CASK and specific siRNA for CASK was designed and constructed as previously described [21, 22] . INS-1E cells were transfected with 4000 ng of overexpression plasmid in 3.5-cm plates for 48 h with 11.1 mM or 25 mM glucose or 10 μl siRNA (100 nM) using Lipofectamine 2000 (Invitrogen, Carlsbad, USA), according to the manufacturer's instructions.
Statistical analysis
Data were presented as the mean ± standard error of the mean (SEM) and analyzed using analysis of variance (ANOVA) with the Tukey's post hoc test (multiple groups) or the Student's t-test (two groups). SPSS 13.0 (SPSS Inc., Chicago, USA) was used for analysis. Two-sided P-values <0.05 were considered statistically significant.
Results
CASK overexpression partially reverses glucotoxicityinduced insulin secretion dysfunction under potassium stimulation
To assess the expression of CASK in pancreatic β cells, CASK protein levels were measured in INS-1E, Min6, and RINm5F cells using western blot analysis. The results showed that CASK (molecular weight of 105.1 kDa) was widely expressed in various pancreatic β cell lines (Fig. 1A) . To confirm the deleterious effect of high glucose on insulin secretion of pancreatic β cells, INS-1E cells were cultured under different concentrations of glucose for 48 h. As shown in Fig. 1B ,C, insulin secretion was decreased significantly when 25 mM of glucose was used, independent of the subsequent glucose or potassium simulation (GSIS or KSIS). Moreover, to further assess the role of CASK in glucotoxicity-induced insulin secretion defect, a CASK overexpression plasmid (pEGFP-N2-CASK) was used. When INS-1E cells were transiently transfected with pEGFP-N2-CASK and cultured under 25 mM glucose for 48 h, the decreased insulin secretion under potassium stimulation was partially reversed (Fig. 1D,E) . However, CASK overexpression did not significantly alter the insulin secretion with glucose stimulation (GSIS) (Fig. 1D,E) . These results suggest that CASK is involved in plasmid (pEGFP-CASK) or control plasmid (pEGFP-N2) for 48 h with 11.1 or 25 mM glucose, then cultured in glucose-free KRB buffer for 1 h, and in KRB buffer with low (3.3 mM) glucose, high (16.7 mM) glucose, or high (50 mM) K + for 1 h. Insulin levels were detected by RIA. Data are presented as the mean ± SEM (n = 6) of three independent experiments. *P < 0.05, **P < 0.01 vs. 5.5 mM or 11.1 mM+pEGFP-N2.
## P < 0.01 vs. 25 mM+pEGFP-N2.
glucotoxicity-induced insulin secretion defects under high potassium stimulation in INS-1E cells.
Glucotoxicity exerts a negative effect on the expression of CASK in INS-1E cells
To evaluate the effects of high-glucose levels on CASK expression, INS-1E cells were incubated with different concentrations of glucose for 48 h or for different time (24, 48, or 72 h). Real-time PCR was performed to determine the mRNA levels of CASK. As shown in Fig. 2A,  B , the mRNA level of CASK was significantly reduced to~65% compared with its own control upon administration of 25 mM glucose for 48 or 72 h, and this reduction was confirmed by western blot analysis (molecular weight of 105.1 kDa; Fig. 2C,D) . To investigate the effect of high glucose on the localization of CASK, immunofluorescence assay was performed. The results showed that high glucose decreased the expression of CASK. However, high-glucose treatment seems to aggregate CASK near the nucleus (Fig. 2E) .
Protein level and activity of HIF1α is increased by highglucose treatment
To investigate whether high glucose could induce HIF1α activation, real-time PCR and western blot analysis were performed. As shown in Fig. 3A , the mRNA level of HIF1α was decreased by~30% under 25 mM glucose. However, the protein level of HIF1α (molecular weight of 116 kDa) was obviously increased under 25 mM glucose treatment for 48 h (Fig. 3C) , while the α-tubulin level remained similar. Furthermore, to assess the activity of HIF1α under high glucose, the mRNA level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the target gene of HIF1α [23] , was detected by real-time PCR using actin as the internal reference. There was a 2.24-fold increase in GAPDH mRNA levels in response to 25 mM glucose (Fig. 3B) , suggesting that the activity of HIF1α is increased. Meanwhile, HIF1β, which can form a dimer with HIF1α under hypoxic conditions, was assessed by real-time PCR. Consistent with previous research, the mRNA level of HIF1β was not significantly different among treatment with different concentrations of glucose ( Supplementary Fig. S1 ).
The negative regulation of CASK by high glucose could be partially mediated by HIF1α
To assess whether the negative regulation of CASK by high glucose is mediated by HIF1α, HIF1α agonist (CoCl 2 ) and selective inhibitor (KC7F2) were used [23, 24] . INS-1E cells were cultured in RPMI-1640 medium with CoCl 2 or KC7F2 with or without 25 mM glucose for 48 h. The GAPDH mRNA levels were analyzed by real-time PCR using actin as the internal reference. The data showed that when INS-1E cells were treated with 100 μM CoCl 2 for 48 h, there was a 1.7-fold increase for GAPDH mRNA levels (Fig. 4A) . When the INS-1E cells were incubated with 5 or 10 μM KC7F2 under 25 mM glucose, the increased GAPDH mRNA levels were decreased (Fig. 4B) . Since agonists could affect cell viability, MTT assays were The protein levels of CASK were analyzed by western blot analysis. α-Tubulin was used as the internal control. (E,F) Intensity of the bands were quantified and normalized to α-tubulin. Data are presented as the mean± SEM (n = 6) of three independent experiments. *P < 0.05, **P < 0.01 vs. control; ## P < 0.01 vs. 25 mM glucose without KC7F2.
performed under each experimental condition, and results showed that they did not affect cell viability ( Supplementary Fig. S2 ). Based on the results of MTT assay, we used 100 μM CoCl 2 and 5 or 10 μM KC7F2 in the subsequent experiments. To examine the effect on CASK expression, INS-1E cells were cultured with or without 100 μM CoCl 2 for 48 h. Western blot analysis was performed to determine the CASK protein level. There was a significant decrease in CASK protein level in response to 100 μM CoCl 2 (Fig. 4C,E) .
INS-1E cells were incubated with 25 mM glucose with or without KC7F2. As shown in Fig. 4D , there was an obvious decrease in CASK protein level in response to 25 mM glucose; however, with simultaneous administration of 25 mM glucose and 10 μM KC7F2, this decrease was partially reversed (Fig. 4D,F) .
Discussion
In the present study, for the first time, we suggest that CASK is involved in glucotoxicity-induced insulin secretion dysfunction mediated by HIF1α in pancreatic β cell line. The pathogenic effects of long-term hyperglycemia may occur when CASK protein level is insufficient, as mediated by the up-regulation of HIF1α protein level, at least in INS-1E cells. Altering the protein level of CASK partly blocked this pathogenic effect, indicating a possible role for CASK in the mediation of the effects of HIF1α with hyperglycemia treatment. T2DM is a progressive metabolic syndrome characterized by elevated blood glucose level and is now reaching epidemic proportions in the world [21, 25] . However, to the best of our knowledge, the mechanisms about the damage of supraphysiologic plasma glucose on pancreatic β cells are still incompletely understood. Studies have shown that glucotoxicity impedes the generation of signals for the secretion of insulin and diminishes the efficiency of the late steps in exocytosis. Several proteins required for exocytosis of secretory granules are down-regulated in T2DM, such as the soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein [26] . In addition, a previous study in our group demonstrated that CASK may play a role in the process of insulin granules anchoring to cell membrane [12] . Based on these results, we hypothesized that CASK may be involved in glucotoxicity-induced insulin secretion dysfunction. In this study, the level of CASK was found to be downregulated by high-glucose levels. In addition, the deficiency of KSIS was partially reversed when INS-1E cells cultured with high concentrations of glucose were transfected with a CASK overexpression plasmid. These findings suggest that CASK could be involved in glucose-induced insulin secretion. However, the CASK overexpression plasmid did not significantly alter the dysfunction of GSIS in INS-1E cells. One possible explanation for this result is that CASK is more likely involved in the process of anchoring or exocytosis of insulin granules and does not play any significant role in the process of energy metabolism and insulin synthesis. To explore this possibility, we transfected INS-1E cells with CASK siRNA and detected the expressions of insulin synthesis genes, including PDX-1, MAFA, and NeuroD, by real-time PCR. Consistent with our previous studies [11, 12] , all of these genes were not affected by siRNA against CASK ( Supplementary Fig. S3 ). Thus, CASK could play a critical role in the process of hyperglycemia-induced insulin dysfunction and CASK is more likely to be involved in the process of anchoring or exocytosis of insulin granules.
Many studies have shown that glucose stimulation can upregulate HIF1α expression [17] [18] [19] . HIF1α acts as a sensor of oxygen level and is composed of a constitutive β subunit and a regulatory α subunit. In the presence of oxygen, HIF1α is hydroxylated by the prolylhydroxylase enzymes (PHD) and is captured by the von Hippel-Lindau (VHL) protein that forms the recognition component of an E3 ubiquitin ligase complex that targets HIF1α for poly-ubiquitination and proteasomal degradation [27] . Conversely, at low oxygen level, HIF1α is no longer hydroxylated by PHD, enabling the stabilized HIF1α to dimerize with the constitutive HIF1β and bind to the hypoxia response element of HIF target genes [27] . Deletion of the VHL gene in pancreatic β cells leads to impaired glucose homeostasis in mice [28] . Moreover, it has been previously reported that hyperoxia reverses glucotoxicityinduced inhibition of insulin secretion in rat INS-1 β cells [19] . In the previous studies, we found that the mRNA level of HIF1α was decreased in INS-1E cells under high-glucose treatment [11, 12] . In addition, Manalo et al. [15] performed a microarray analysis to analyze CASK expression in human arterial endothelial cells exposed to a constitutively active form of HIF1α, and found that the level of CASK was increased by 2.6-fold. Therefore, CASK level could be regulated by HIF1α. In this study, we found that the HIFα activator, CoCl 2 , could reduce the protein level of CASK, and that the HIF1α selective inhibitor, KC7F2, could partially reverse the decreased level of CASK under 25 mM glucose treatment.
In conclusion, our data suggest that CASK is involved in glucotoxicity-induced insulin secretion defect, and CASK could be regulated by HIF1α in the pancreatic β cell line INS-1E. HIF1α plays a repression role on CASK gene expression. It has been shown that hypoxia directly impacts on protein stability of CASK [16] , therefore, we speculate that high glucose may affect transcription and protein stability of CASK. This study broadens our understanding and brings new perspectives on the mechanisms of glucotoxicity. Nevertheless, further CHIP assay should be performed to understand how HIF1a affects the expression of CASK and validate these key findings in primary islets.
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